2024-12-28 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a pharmaceutical company.  The cumulative return of LLY is 568.61%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 118.39%. The difference in cumulative returns is 450.2%, placing it at the 72.1st percentile of its historical range compared to the S&P 500.  This indicates strong relative performance.  The provided alpha values of 0.0 suggest that the outperformance is not explained by market-wide factors.


**2. Recent Price Movement:**

* **Closing Price:** $783.17
* **5-Day Moving Average:** $787.40
* **20-Day Moving Average:** $793.91
* **60-Day Moving Average:** $827.85

The stock price is currently below its 5, 20, and 60-day moving averages, suggesting a possible short-term downtrend.


**3. Technical Indicators and Expected Return:**

* **RSI:** 33.82 – This suggests the stock is currently in oversold territory.
* **PPO:** 0.26 – A positive PPO indicates bullish momentum, although relatively weak given the RSI.
* **Relative Strength Change (20-day):** +2.8 – Indicates a recent short-term upward trend.
* **Expected Return (2+ years):** 115.4% – This represents a substantial outperformance compared to the S&P 500 over the long term.


**4. Recent Earnings Analysis:**

The provided earnings data shows significant volatility in both EPS and revenue.  While revenue generally increased, EPS fluctuated drastically.  There's a notable drop in EPS from Q2 2024 ($3.29) to Q3 2024 ($1.08).  There is also a negative EPS in Q4 2023 and Q4 2024 (-$0.06), which needs further investigation to understand the underlying reasons.  Without access to expectations, we cannot determine if these results beat or missed predictions.


**5. Financial Information Analysis:**

* **Revenue:** Revenue has been relatively stable, with some fluctuation.
* **Profit Margin:** Profit margins are consistently high, around 80%, demonstrating strong profitability.
* **Equity:** Equity has generally increased, signifying a healthy financial position.
* **ROE:** Return on equity shows significant variation, indicating potentially volatile profitability drivers.


**6. News and Recent Issues:**

This section requires information about recent earnings news (within the last two days), market outlook, and analyst opinions, which was not provided in the original prompt.


**7. Overall Analysis:**

LLY has demonstrated exceptional long-term performance, significantly outperforming the S&P 500. However, recent price action suggests a potential short-term downturn.  Technical indicators point to oversold conditions but also suggest some positive momentum.  Earnings show strong profitability but significant volatility in EPS, warranting further investigation into the underlying reasons for these fluctuations. The high projected long-term return is promising, but potential risks associated with the volatility of EPS should be considered.  More information on recent news and analyst opinions would provide a more comprehensive assessment.


**8. Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice.  Independent research and consultation with a financial advisor are recommended before making any investment decisions.
